Skip to main

The Cost of Survival: Navigating the Financial Burden of Transplantation

The Cost of Survival: Navigating the Financial Burden of Transplantation

Power2Save and The AST's Community Education Committee welcomes Drs. Ashoor, Leiber, Westphal, Pradhan, and Iuppa as they engage in an insightful discussion with Michael Sole, Liver Recipient

  • 1:00 PM - 2:00 PM EST
  • Virtual

Join Power2Save and the AST Community Education Committee as we explore the growing financial burden of transplantation and its impact on patients and families. The discussion will include provider perspectives and a candid conversation with Michael Sole, liver recipient, on his personal experience managing transplant-related costs

This session will provide an overview of financial challenges before transplant, including drug coverage concerns, disability and insurance navigation, fundraising, and available resources. Don't miss this opportunity to learn and ask questions in a live Q&A session at the end!

Moderator:
Isa F. Ashoor, MD FAAP
Pediatric Nephrologist
Division of Nephrology
Department of Pediatrics
Boston Children’s Hospital

Panelists:
Michael Sole MS, LAT, ATC, CSCS
Liver Recipient

Sarah R. Lieber, MD MSCR
Assistant Professor of Medicine
UT Southwestern Medical Center
Division of Digestive and Liver Diseases

Faruq Pradhan, MBBCh, FRCPC
Assistant Professor, Transplant Hepatologist
Division of Gastroenterology and Hepatology
University of Nebraska Medical Center

Jennifer Iuppa Melaragno, PharmD, BCPS, FAST, FCCP
Clinical Pharmacist, Abdominal Transplantation
University of Rochester Medical Center

Scott G. Westphal, MD
Associate Professor, UNMC Division of Nephrology
Program Director, UNMC Nephrology Fellowship
University of Nebraska Medical Center

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi